ACRV: Acrivon Therapeutics, Inc. Stock

by  •  • Comments Off on ACRV: Acrivon Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 173.43
Enterprise Value ($M) 130.01
Book Value ($M) 196.89
Book Value / Share 6.32
Price / Book 0.88
NCAV ($M) 171.19
NCAV / Share 5.50
Price / NCAV 1.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 12.75
Current Ratio 12.75

Balance Sheet (mrq) ($M)
Current Assets 188.98
Assets 214.68
Liabilities 17.79
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
07-10 13G/A Chione Ltd 17.30 -0.21
04-15 13G/A Perceptive Advisors Llc 17.40 78.23
04-11 13D/A Ra Capital Management, L.p. 27.10 73.52
02-14 13G/A Citadel Advisors Llc 7.40
02-14 13G/A Marshall Wace North America L.P. 2.70 -51.16
02-13 13G/A Sands Capital Ventures, LLC 7.40 -0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 6,468 20,251 31.94
2025-02-03 6,780 25,435 26.66
2025-01-31 6,694 20,604 32.49
2025-01-30 2,810 10,636 26.42

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ADMA – ADMA Biologics, Inc. AFMD – Affimed N.V.


Financial data and stock pages provided by
Fintel.io